Summary
Motility was recorded from the corpus, antrum and small intestine of the urethane anaesthetised ferret. The gastrointestinal effects of the highly emetic cytotoxic anticancer agent, cisplatin were investigated following intravenous administration (10 mg/kg i. v.).
Following injection, cisplatin induced a prompt onset (< 2 min) increase in motility (tone and contraction amplitude) in all regions with a duration of < 15 min. Acute vagotomy did not abolish the effect but reduced the peak amplitude in the antrum only. Chronic subdiaphragmatic vagotomy significantly enhanced the cisplatin-induced rise in tone in the corpus, the contraction amplitude in the antrum and the duration of the response in the duodenum. The stimulatory effect of cisplatin was blocked in all regions by atropine but not naloxone or the 5-HT3 receptor antagonist ondansetron.
This study reports a previously undescribed gastrointestinal motility effect of cisplatin in vivo that is temporally dissociated from emesis. It is proposed that the results provide evidence for a neuroactive effect of cisplatin on enteric cholinergic neurones.
Similar content being viewed by others
References
Akwari O (1983) The gastrointestinal tract in chemotherapy induced emesis, A final common pathway. Drugs 25 [Suppl 1]:18–34
Andrews PLR, Bingham S (1990) Adapatation of the mechanisms controlling gastric motility following chronic vagotomy in the ferret. Exp Physiol 75:811–825
Andrews PLR, Lawes INC (1984) Interactions between splanchnic and vagus nerves in the control of mean intragastric pressure in the ferret. J Physiol (Lond) 351:473–490
Andrews PLR, Scratcherd T (1980) The gastric motility patterns induced by direct and reflex excitation of the vagus nerves in the anaesthetized ferret. J Physiol (Lond) 302:363–378
Andrews PLR, Wood KL (1988) Vagally mediated gastric motor and emetic reflexes evoked by stimulation of the antral mucosa in anaesthetized ferrets. J Physiol (Lond) 395:1–16
Andrews PLR, Hawthorn J, Sanger GJ (1987) The effect of abdominal nerve lesions and a novel 5-HT -M receptor antagonist on cytotoxic and radiation induced emesis in the ferret. J Physiol (Lond) 382:47
Andrews PLR, Davis CJ, Bingham S, Davidson HIM, Hawthorn J, Maskell L (1990) The abdominal visceral innervation and the emetic reflex: Pathways, pharmacology and plasticity. Can J Physiol Pharmacol 68:325–345
Barnes NM, Costall B, Naylor RJ, Tattersall FD (1988) Identification of 5-HT3 recognition sites in the ferret area postrema. J Pharm Pharmacol 40:586–588
Bermudez J, Boyle EA, Miner W, Sanger GJ (1988) The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. Br J Cancer 58:644–650
Borison HL, McCarthy LE (1983) Neuropharmacology of chemotherapy induced emesis. Drugs 25 [Suppl 1]:8–17
Chey RD, Lee KY, Asbury R, Chey WY (1988) Effect of cisplatin on myoelectric activity of the stomach and small intestine in dogs. Dig Dis Sci 33:338–344
Daniel EE, Collins SM, Fox JET, Huizinga JD (1989) Pharmacology of drugs acting on gastrointestinal motility. In: Wood JD (ed) Handbook of physiology. The gastrointestinal system, vol 1, motility and circulation, part 1. American Physiological Society, Bethesda, Md, USA, pp 715–759
Davidson HIM, Andrews PLR (1988) Immediate stimulation of gastrointestinal motility by emetic doses of cisplatin in the ferret. Nausea and Vomiting: Multidisciplinary Perspective Proceedings Symposium, p 28, Ottawa, Canada
Davidson HIM, Andrews PLR (1990) Activation of vagal afferent fibres by the cytotoxic drug cisplatin. J Anton Nerv Syst 31:A179
Davis CJ (1988) Neuropharmacological investigations into the mechanisms of emesis caused by cytotoxic drugs and radiation. DPhil Thesis, University of Oxford
Florczyk AP, Schurig JE, Bradner WT (1982) Cisplatin-induced emesis in the ferret: A new animal model. Cancer Treat Rep 66:187–189
Fukui H, Yamamoto OM, Saito S (1992) Vagal afferent fibres and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs. Jpn J Pharmacol 59:221–226
Hawthorn J, Ostler KJ, Andrews PLR (1988) The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret. Q J Exp Physiol 73:7–21
Higgins GA, Kilpatrick GJ, Bunce KT, Jones RJ, Tyers MB (1989) 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97:247–255
Hill JM, Loeb E, Maclellan H, Hill NO, Khan A, King JJ (1975) Clinical studies of platinum coordination compounds in the treatments of various malignant diseases. Cancer Chemother Rep 59:647–659
Ito J, Okada M, Abo T, Okamoto Y, Yamashita T, Takahashi K (1987) Experimental study on the control of cisplatin-induced emesis in dogs. Gan To Kagaku Royoho 14:706–710
Jansson G, Lisander B (1969) On adrenergic influences on gastric motility in chronically vagotomized cats. Acta Physiol Scand 76:463–471
Lang IM, Sarna SK, Condon RE (1986) Gastrointestinal motor correlates of vomiting in the dog: quantification and characterisation as an independent phenomenon. Gastroenterology 90:40–47
Lee KY, Park HJ, Chang WY (1983) Cholinergic role on release and action of motilin. Peptides 4:375–380
Makale MT, King GL (1992) Surgical and pharmacological dissociation of cardiovascular and emetic responses to intragastric CUSO4. Am J Physiol 263:R284–291
Miner WD, Sanger GJ (1986) Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497–499
Schwörer H, Racke K (1989) Effects of cisplatin on the release of 5-hydroxytryptamine from guinea-pig small intestine: Involvement of 5-HT3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 339:R96
Schwörer H, Racke K, Kilbinger H (1991) Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea pig: Involvement of 5-HT3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 344:143–149
Stables R, Andrews PLR, Bailey HE, Costall B, Gunning SJ, Hawthorn J, Naylor RJ, Tyers MB (1987) Antiemetic properties of the 5-HT3-receptor antagonist, GR38032F. Cancer Treat Rev 14:333–336
Thompson PI, Bingham S, Andrews PLR, Patel N, Joel SP, Slevin ML (1992) Morphine 6-glucuronide: A metabolite of morphine with greater emetic potency than morphine in the ferret. Br J Pharmacol 106:3–8
Author information
Authors and Affiliations
Additional information
Present address: Department of Dietetrics + Nutrition, Queen Margaret College, Clermiston Terrace, Edinburgh EH12 8TS
Correspondence to H.I.M. Davidson at the present address
Rights and permissions
About this article
Cite this article
Davidson, H.I.M., Andrews, P.L.R. Stimulation of gastrointestinal motility by cisplatin in the ferret: activation of an intrinsic cholinergic mechanism dissociated from emesis. Naunyn-Schmiedeberg's Arch Pharmacol 347, 506–513 (1993). https://doi.org/10.1007/BF00166743
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00166743